CUSIP 492327101COMKROSQ4 2025
53 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 2.29M | $46.64M |
| 2 | Vanguard Group Inc | 1.53M | $31.06M |
| 3 | Arrowstreet Capital, Limited Partnership | 1.33M | $27.17M |
| 4 | State Street Corp | 1.08M | $21.91M |
| 5 | Madison Avenue Partners, LP | 823.7K | $16.77M |
| 6 | Orbimed Advisors LLC | 804.2K | $16.37M |
| 7 | Qube Research & Technologies Ltd | 783.9K | $15.96M |
| 8 | Jacobs Levy Equity Management, Inc | 768.4K | $15.65M |
| 9 |
| 4 | Feb 17, 2026 | Exoduspoint Capital Management, LP | 13G/A | 0.0% | 13.4K | SEC |
| 5 | Jan 30, 2026 | The Vanguard Group | 13G/A | 5.0% | 1.53M | SEC |
| 6 | Nov 18, 2025 | Exoduspoint Capital Management, LP | 13G | 6.3% | 1.91M | SEC |
| 7 | Oct 27, 2025 | D. E. Shaw &Amp; Co., L.P. | 13G | 5.1% | 1.55M | SEC |
| 8 | Oct 22, 2025 | Tang Capital Management, LLC | 13G | 7.9% | 1.52T | SEC |
| 9 | Oct 16, 2025 | Pontifax Management 4 Gp (2015) Ltd. | 13D/A | — | — | SEC |
| 10 | Oct 15, 2025 | Adar1 Capital Management, LLC | 13D/A | — | — | SEC |
See the full Schedule 13D/13G history for Keros Therapeutics Inc.
Unlock full history| D. E. Shaw & Co., Inc. |
| 755.5K |
| $15.38M |
| 10 | Federated Hermes, Inc. | 654.7K | $13.33M |